Skip to main content

Telix Pharmaceuticals Ltd

TLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002007191

No open-market purchases or sales by Telix Pharmaceuticals Ltd insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $36.6M in total; no superinvestor holds it.

Other share classesTLPPF

Superinvestors holding TLX, Q2 2026

See all superinvestors

No superinvestor reported holding TLX in Q2 2026.